default author photo

Xin Yao

First Affiliated Hospital of Nanjing Medical University

United States

SCHOLARLY PAPERS

1

DOWNLOADS

490

TOTAL CITATIONS

9

Scholarly Papers (1)

1.

Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter Trial

Number of pages: 19 Posted: 29 Aug 2020
Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China (USTC) - Division of Molecular Medicine, Drug Clinical Trail Institution, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Huazhong University of Science and Technology - Department of Infectious Diseases, Fuyang 2nd People’s Hospital - Department of Internal Medicine, Hunan Provincial Clinical Research Center for Respiratory Disease, ntensive Care Unit, The First Affiliated Hospital of University of Science and Technology of China, Intensive Care Unit, the First Affiliated Hospital of University of Science and Technology of China, u'an people's Hospital affiliated to Anhui Medical University, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Bengbu Medical College, Clinical Research Center for Respiratory Disease, Anhui Medical University - Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, Department of Oncology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Endocrinology, the First Affiliated Hospital of University of Science and Technology of China, Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Intensive Care Unit, the First Affiliated Hospital of University of Science and Technology of China, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China (USTC) - Division of Molecular Medicine, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of University of Science and Technology of China and University of Science and Technology of China (USTC) - Department of Pulmonary and Critical Care Medicine
Downloads 490 (144,058)
Citation 9

Abstract:

Loading...

Tocilizumab, Covid-19, cytokine storm